An interventional study of Calcaneocuboid arthrodesis in Calcaneocuboid Osteoarthritis Secondary to Trauma, sponsored by Assiut University. Recruiting at 1 site in Egypt. Open to participants aged 18 Years to 60 Years. Per ClinicalTrials.gov, last updated 2023-08-21.
Sponsored by Assiut University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 13 studies in Osteoarthritis by Assiut University — 8 open to participants now, 8 under way, none of them phase 3. Osteoarthritis · Assiut University.
Among the 13 studies in Osteoarthritis by Assiut University, this one is one of 2 that started in 2023, is one of 7 with no phase, and was the 6th registered.
2,978 studies on the registry are indexed under Osteoarthritis; 438 are open to participants now.
Browse Osteoarthritis studies →8 of the 13 studies in Osteoarthritis by Assiut University are open now, in 1 country. Recruiting first, the newest first:
Assiut University
Ages 18–70
Assiut University
Ages 18+
Assiut University
Ages 18+ · Healthy volunteers
Assiut University · Sites in Egypt
Ages 40+
Assiut University
By country, each count listing its studies:
Of the 285 Osteoarthritis studies recruiting now, 158 (55%) set no upper age limit and 70 (25%) stop at 75 or younger; 22 take children under 18; 31 take healthy volunteers.
This study: 18 Years to 60 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
13 studies; the count open now beside each. This study's row is marked.
First in 2017; this study’s year is marked. 2 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 3 is below the median of 80 across 2,242 interventional studies indexed under Osteoarthritis.
Median enrollment 60 across the 8 interventional studies, 51 across the 5 observational. None of them has completed or been terminated yet.
This tab as a report to print or save as PDF → With an account.
Assiut University is the lead sponsor of 5,094 studies on the registry; 2,187 are open to participants now.
Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
3 of the studies in Osteoarthritis by Assiut University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07566520Assiut UniversityPrevalence of Sarcopenia and Its Associated Factors in Patients With Knee Osteoarthritis in a Tertiary Care Hospital in Upper Egypt | 2027-04 |
| NCT07751263Assiut University15-Hydroxyprostaglandin Dehydrogenase in Osteoarthritis and Ankylosing Spondylitis | 2027-08-02 |
| NCT07784257Assiut UniversityDiagnostic Accuracy of Triphasic Bone Scan and SPECT/CT in Foot and Ankle Osteoarthritis | 2027-08-20 |
Add all 3 to your calendar (.ics) → With an account.
Among the 13 studies in Osteoarthritis by Assiut University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Investigators aim to compare clinical and radiological outcome of use of plate versus screw fixation for calcaneocuboid arthrodesis in adult population.
The calcaneocuboid joint is stable, even although multiple conditions might affect the joint, ranging from osteoarthritis to fracture, subluxation, and dislocation. Calcaneocuboid arthrodesis is more commonly performed as an adjunct procedure with other rearfoot procedures such as triple arthrodesis and is less used as isolated fusion.[1],[2],[3] What the most effective and least cost method for calcaneocuboid arthrodesis?! Many conditions that may affect foot that cause pain ; and there are many methods for relieve that pain , one of these is arthrodesis , and calcaneocuboid joint one of the most affected joints , and commonly we do calcaneocuboid arthrodesis as a part of triple arthrodesis ( subtalar , talonavicular , calcaneocuboid ); The traditional fixation for a calcaneocuboid (CC) arthrodesis in triple arthrodesis is with a 6.5-mm cancellous screw. This procedure can be technically challenging. Fixation with a locking compression plate (LCP) may be easier to perform while achieving compression perpendicular to the fusion site. Investigators suppose that plate is more powerful than screw in calcaneocuboid arthrodesis. The purpose of this study was to compare the load to failure and the stiffness for each fixation method. [4],[5],[6] literature reveal that: More stability to the fusion site can be applied by using plate fixation. Rationale of the research that: calcaneocuboid arthrodesis with screw is effective and least cost compare to plate fixation? [7]
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
all patients who will be operated by calcaneocuboid fusion for any indication age range 18-65 no paralytic patients
Exclusion Criteria:
Calcaneocuboid arthrodesis in triple arthrodesis by Screw fixation
Procedure: Calcaneocuboid arthrodesis
Calcaneocuboid arthrodesis in triple arthrodesis
Assess calcaneocuboid arthrodesis union
calcaneocuboid arthrodesis union by RUST score
Time frame: One year
Start is estimated for Sep 2023; primary completion for Aug 2025, 22 months later.
Of 578 non-industry interventional studies with no phase under Osteoarthritis, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 51. This study's planned 22 months is below that.
Counting every sponsor, half of 713 studies reached it within 28 months; a quarter within 11 and three quarters within 57.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.